Indwelling Pleural Catheters: a Self-management Intervention
PACMAN
3 other identifiers
observational
116
1 country
1
Brief Summary
A pleural effusion is a build-up of fluid around the lung. In the UK, about quarter of a million people develop a pleural effusion each year. They are usually caused by advanced cancer or heart, kidney, or liver failure. People with a pleural effusion feel breathless and can't do the things they want to. Draining the fluid improves breathlessness and quality of life. This can be done by inserting a semi-permanent tube called an indwelling pleural catheter (IPC). This is drained at home about three times a week. Drainage is usually done by a community nurse. However, it can be done by the patient or family/unpaid carers - this is called self-management. Self-management gives the patient the freedom to drain their IPC when they need to, without having to wait at home until a nurse is available. It reduces the burden on community nursing services. Despite these benefits, not all patients get the opportunity to self-manage. The aim of this study is to help more patients self-manage if they want to. We will achieve this through three stages: Stage 1: We will talk to patients with IPCs as well as their families/carers to find out their views on self-management and what stops people who could self-manage from doing so. We know that patients with an IPC can be frail. Often their families/carers are already doing a lot to support them. We will ask what might help them to self-manage if they would like to. Stage 2: We will talk to healthcare professionals (HCPs) looking after patients with IPCs to understand what they think about self-management. This will include community nurses and the hospital teams who put IPCs in. Stage 3: Along with our patients, their families/unpaid carers and HCPs, we will hold workshops to design an intervention that will help people to self-manage IPCs. We don't know what this intervention will look like yet. From talking to patients and families who already self-manage, we have found they like to learn from a demonstration on their own IPC followed by supervised self-management until they feel confident. Therefore, our intervention may include training sessions for HCPs on how to teach self-management. This study grew from conversations with our patients. People with an IPC, family members and community nurses helped design the study. Our patient and public involvement (PPI) group will help design study materials and guide the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 12, 2024
CompletedFirst Submitted
Initial submission to the registry
March 12, 2025
CompletedFirst Posted
Study publicly available on registry
April 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedApril 11, 2025
March 1, 2025
1.5 years
March 12, 2025
April 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Capturing Health Care Professionals attitudes toward and beliefs about self-management
Data will be collected via focus groups and interviews. The different data collection designs reflect the nature of how the two groups of HCPs work and working patterns. The topic guide for the two activities will thus be largely the same and given the common subject matter it will be possible to analyse the qualitative data from these two approaches together. There will be some additional, group-specific, questions reflecting the different roles these two HCP groups play in the patient care pathway. The four objectives to achieve this are: 1. to identify support needs in relation to IPC and how unfulfilled needs impact ability to self-manage. 2. to identify barriers and motivators to IPC self-management among patients and family/unpaid carers. 3. to understand HCP attitudes toward, and practices related to, IPC-self-management. 4. to work with stakeholders to co-develop an intervention to facilitate IPC self-management.
Periprocedural
Study Arms (3)
Patients
Patients who have (or have had) an IPC.
Family members and unpaid carers
Family members and unpaid carers of patients who have (or have had) an IPC.
Healthcare professionals
Community nurses involved in IPC care and healthcare professionals involved in IPC insertion.
Eligibility Criteria
UK patients who have (or have had) an indwelling pleural catheter, and their family/unpaid carers. UK healthcare professionals who work with patients who have IPCs, including community nurses and IPC-insertion centre staff.
You may qualify if:
- Stage 1 - Patients and family/unpaid carers
- Adult (\>18 years) who has (or has had) an IPC OR
- Adult family member or unpaid carer of a patient who has (or has had) an IPC
- Patients may currently be self-managing or receiving CN care.
- Stage 2 - Healthcare professionals
- Community nurse: experience of caring for a patient with an IPC within the last 12 months and signed-off as competent in IPC management
- IPC-insertion site staff: any HCP involved in discussion with patients about post-insertion IPC care
- Stage 3 - Co-design groups
- o as above
You may not qualify if:
- Stage 1 - Patients
- Patient with a life expectancy of less than 6 weeks
- Patient or family/unpaid carer who lacks capacity to offer informed consent (as judged by a suitably qualified HCP in accordance with Good Clinical Practice guidelines)
- Stage 2 - Health care professionals o None
- Stage 3 - Co-design groups
- o As above
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Norfolk and Norwich University Hospitals NHS Trust
Norwich, Norfolk, NR4 7UY, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adam M Dr Peel
Norfolk and Norwich University Hospitals NHS Trust
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 12, 2025
First Posted
April 4, 2025
Study Start
November 12, 2024
Primary Completion
April 30, 2026
Study Completion
April 30, 2026
Last Updated
April 11, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- Throughout study duration.
- Access Criteria
- Stakeholders including - but not limited to: * Regional integrated care boards, and participating NHS trusts / study recruitment sites. * Influential third sector organisations such as Mesothelioma UK * IPC manufacturers * Relevant charities such as Breast Cancer UK and the Roy Castle lung cancer foundation. * Via the FutureNHS platform. * Members of the BTS Pleural Guideline Development group
The study will be publicised to stakeholders. Online resources may be hosted and promoted via the MyPleuralEffusionJourney and UKPS websites. Further opportunities for promotion will be explored including direct contact with services previously identified as using self-management infrequently.